Pneumococcal conjugate second or third-dose vaccines (PCVc) in Malawi
Malawi: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 91.0% in 2025. ◆ Volatile
Latest (2025)
91.0%
Change on year
down 1.1%
World rank
61st
of 194 countries
All-time high
99.0%
in 2012
All-time low
0.0%
in 2008
Years of data
18
2008–2025
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Malawi, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
In 2025, pneumococcal conjugate second or third-dose vaccines (pcvc) in Malawi stood at 91.0%.
Compared with earlier readings it is down 1.1% on the previous year and up 3.4% over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in Malawi peaked at 99.0% in 2012 and was at its lowest, 0.0%, in 2008.
That places Malawi 61st out of 194 countries with data for 2025, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Malawi, year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 0.0% | — |
| 2011 | 0.0% | — |
| 2012 | 99.0% | — |
| 2013 | 89.0% | -10.1% |
| 2014 | 87.0% | -2.2% |
| 2015 | 88.0% | +1.1% |
| 2016 | 83.0% | -5.7% |
| 2017 | 88.0% | +6.0% |
| 2018 | 92.0% | +4.5% |
| 2019 | 95.0% | +3.3% |
| 2020 | 93.0% | -2.1% |
| 2021 | 93.0% | +0.0% |
| 2022 | 87.0% | -6.5% |
| 2023 | 91.0% | +4.6% |
| 2024 | 92.0% | +1.1% |
| 2025 | 91.0% | -1.1% |
Malawi compared with similar countries
- Malawi's 91.0% is above the median for low income countries, which is 80.0%, 1.1× the median. (25 countries reporting)
- Malawi's 91.0% is above the median for Sub-Saharan Africa, which is 82.5%, 1.1× the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 72.1% | 0.0% | 99.0% | 10 |
| 2020s | 91.2% | 87.0% | 93.0% | 6 |
Countries ranked near Malawi
More health data for Malawi
- Un projection of annual infant deaths, annual growth rate -0.8368 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.9312 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 856.3 deaths per 1,000 people (2090)
- Number of infants who die before age 1 6,399 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 2 (2025)
- Population ages 00-04, female, annual growth rate 1.61 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0714 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.63 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in Malawi?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in Malawi was 91.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Malawi?
- The highest recorded value was 99.0% in 2012.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Malawi?
- The lowest recorded value was 0.0% in 2008.
- How does Malawi rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Malawi ranks 61st out of 194 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) rising or falling in Malawi?
- Over the last ten years it is up 3.4%. The long-run trend across the full record is volatile.
- Where does this Malawi data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).